| scholarly article | Q13442814 |
| P356 | DOI | 10.7326/0003-4819-131-8-199910190-00004 |
| P698 | PubMed publication ID | 10523217 |
| P50 | author | Paul Ridker | Q7153226 |
| Julie E. Buring | Q67224421 | ||
| Charles H Hennekens | Q89527500 | ||
| P2093 | author name string | Kundsin R | |
| Shih J | |||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Cytomegalovirus | Q6946 |
| antibody | Q79460 | ||
| Helicobacter pylori | Q180556 | ||
| cardiovascular disease | Q389735 | ||
| Helicobacter pylori infectious disease | Q4497153 | ||
| Chlamydia pneumoniae | Q62869737 | ||
| cardiovascular disease in women | Q105047283 | ||
| P304 | page(s) | 573-577 | |
| P577 | publication date | 1999-10-01 | |
| P1433 | published in | Annals of Internal Medicine | Q564416 |
| P1476 | title | Baseline IgG antibody titers to Chlamydia pneumoniae, Helicobacter pylori, herpes simplex virus, and cytomegalovirus and the risk for cardiovascular disease in women | |
| P478 | volume | 131 |
| Q38495577 | A Meta-Analysis of the Association between Helicobacter pylori Infection and Risk of Coronary Heart Disease from Published Prospective Studies |
| Q46831663 | A study of arteriosclerosis in healthy subjects with HBV and HCV infection |
| Q30998860 | A systematic comparison of the quality and volume of published data available on novel risk factors for stroke versus coronary heart disease |
| Q33763278 | An Unsettled Debate About the Potential Role of Infection in Pathogenesis of Atherosclerosis |
| Q37873319 | Antibiotic use and risk of ischemic stroke in the elderly |
| Q33935098 | Antibiotics in the prevention and treatment of coronary heart disease |
| Q37865490 | Association of raised titres of antibodies to Chlamydia pneumoniae with a history of pre-eclampsia |
| Q37870054 | C-reactive protein, Helicobacter pylori, Chlamydia pneumoniae, cytomegalovirus and risk for myocardial infarction |
| Q43967362 | Cardiovascular risk factors in subjects with Helicobacter pylori infection |
| Q37346172 | Chlamydia pneumoniae IgG titres and coronary heart disease: prospective study and meta-analysis |
| Q33905858 | Chlamydia pneumoniae and atherosclerosis: critical assessment of diagnostic methods and relevance to treatment studies |
| Q37867881 | Chlamydia pneumoniae and future risk in patients with coronary heart disease |
| Q37847433 | Chlamydia pneumoniae and progression of subclinical atherosclerosis |
| Q33972282 | Chlamydia pneumoniae serology: importance of methodology in patients with coronary heart disease and healthy individuals |
| Q35121619 | Chlamydia pneumoniae seropositivity in adults with acute ischemic stroke: A case-control study |
| Q37871833 | Chlamydia pneumoniae, Helicobacter pylori and cytomegalovirus infections and the risk of peripheral arterial disease in young women |
| Q43761516 | Chronic Helicobacter pylori infection and ischemic stroke subtypes |
| Q34514051 | Chronic infections and atherosclerosis/thrombosis |
| Q33971224 | Circulating nucleic acids of Chlamydia pneumoniae and cytomegalovirus in patients undergoing coronary angiography |
| Q37870081 | Combined role of the Lewis antigenic system, Chlamydia pneumoniae, and C-reactive protein in unstable angina |
| Q37101524 | Cytomegalovirus in Plasma of Acute Coronary Syndrome Patients |
| Q47981593 | Effect of periodontal treatment on the serum antibody levels to heat shock proteins |
| Q77122215 | Evidence for infection with Helicobacter pylori in patients with acute myocardial infarction |
| Q34168418 | Extraintestinal manifestations of Helicobacter pylori: a concise review |
| Q43641878 | Helicobacter pylori infection as an independent risk factor for cerebral ischemia of atherothrombotic origin |
| Q36614560 | Herpesvirus Infections and Childhood Arterial Ischemic Stroke: Results of the VIPS Study |
| Q36940615 | Herpesvirus Infections and Risk of Frailty and Mortality in Older Women: Women's Health and Aging Studies |
| Q34973446 | High sensitivity C-reactive protein: an emerging role in cardiovascular risk assessment |
| Q43417727 | Higher immunoglobulin G antibody levels against cytomegalovirus are associated with incident ischemic heart disease in the population-based EPIC-Norfolk cohort |
| Q37320829 | Individual pathogens, pathogen burden and markers of subclinical atherosclerosis: the Multi-Ethnic Study of Atherosclerosis |
| Q36414448 | Infection of vascular endothelial cells with human cytomegalovirus under fluid shear stress reveals preferential entry and spread of virus in flow conditions simulating atheroprone regions of the artery |
| Q45527481 | Influence of hepatitis C virus infection on soluble cellular adhesion molecules in hemodialysis patients. |
| Q44054655 | Lack of association of Helicobacter pylori infection with coronary artery disease and frequency of acute myocardial infarction or death |
| Q42255924 | Myocardial perfusion defects in patients with chronic hepatitis B infection |
| Q44213250 | Novel risk factors for peripheral arterial disease in young women. |
| Q34465370 | Potential infectious etiologies of atherosclerosis: a multifactorial perspective |
| Q34405221 | Predictors of C-reactive protein in the national social life, health, and aging project |
| Q37870946 | Procoagulant and inflammatory response of virus-infected monocytes. |
| Q37865613 | Relation of Chlamydia pneumoniae infection to documented coronary artery disease in Shiraz, Southern Iran |
| Q37872836 | Relation of antibiotic use to risk of myocardial infarction in the general population |
| Q37868247 | Relationship between infectious burden, systemic inflammatory response, and risk of stable coronary artery disease: role of confounding and reference group |
| Q35121896 | Salivary immunoglobulins and prevalent coronary artery disease |
| Q24669772 | Socioeconomic status, pathogen burden and cardiovascular disease risk |
| Q34500682 | Stress, inflammation and cardiovascular disease |
| Q37205516 | The association between current Helicobacter pylori infection and coronary artery disease |
| Q58209963 | The central roles of obesity-associated dyslipidaemia, endothelial activation and cytokines in the Metabolic Syndrome—an analysis by structural equation modelling |
| Q80814133 | The incidence of infectious diseases and changes in the mortality of atherosclerosis-related complications in the Czech population over the past two decades |
| Q33749010 | The influence of persistent pathogens on circulating levels of inflammatory markers: a cross-sectional analysis from the Multi-Ethnic Study of Atherosclerosis |
| Q34605356 | The role of infection in the genesis and complications of atherosclerosis |
| Q80339329 | Toxic epidermal necrolysis induced by a triple-drug regimen for helicobacter pylori eradication |
| Q37865389 | Update of antibiotic trials for secondary prevention of coronary heart disease |
| Q34011168 | Weighing the evidence for infection as a risk factor for coronary heart disease |
Search more.